Mirum Pharmaceuticals Inc (MIRM)
24.07
-0.68
(-2.75%)
USD |
NASDAQ |
May 17, 16:00
24.07
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Long Term Debt (Quarterly): 306.84M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 306.84M |
December 31, 2023 | 306.42M |
September 30, 2023 | 306.02M |
June 30, 2023 | 305.61M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2021
306.84M
Maximum
Mar 2024
102.07M
Average
--
Median
Jun 2021
Total Long Term Debt (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 0.00 |
Sarepta Therapeutics Inc | 1.239B |
Puma Biotechnology Inc | 100.02M |
Reneo Pharmaceuticals Inc | -- |
Tharimmune Inc | -- |